Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 22, 2022

Cost-Effectiveness of SGLT2is vs DPP4is in Patients With Type 2 Diabetes With and Without Established Cardiovascular Disease

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Cost-effectiveness of SGLT2is versus DPP4is among type 2 diabetes patients with and without established cardiovascular disease: A model-based simulation analysis using 10-year real-world data and targeted literature review
Diabetes Obes Metab 2022 Apr 04;[EPub Ahead of Print], ZY Peng, CT Yang, HT Ou, S Kuo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading